What is a pancreatic tumor

What is pancreatic tumor? This question is of greatest concern to patients with pancreatic tumor. Pancreatic tumor is a highly malignant digestive tract tumor that is difficult to diagnose and treat. About 90% of pancreatic tumors are ductal adenocarcinomas originating from the glandular duct epithelium. Its morbidity and mortality rates have increased significantly in recent years, and it is one of the malignant tumors with the worst prognosis.

The early diagnosis rate of pancreatic tumors is not high, the surgical mortality rate is high, and the cure rate is very low. The incidence rate of this disease is higher in men than in women, with a male-to-female ratio of 1.5 to 2:1. Male patients are far more common than premenopausal women, and the incidence rate in postmenopausal women is similar to that in men.

The cause of pancreatic tumors is not yet very clear. Its occurrence is related to smoking, drinking, high-fat and high-protein diets, excessive coffee drinking, environmental pollution and genetic factors. Survey reports in recent years have found that the incidence of pancreatic tumors in people with diabetes is significantly higher than that in the general population. Some people have also noticed that there is a certain relationship between patients with chronic pancreatitis and the incidence of pancreatic tumors, and found that the proportion of patients with chronic pancreatitis who develop pancreatic tumors is significantly increased. In addition, there are many other factors that are related to the occurrence of this disease, such as occupation, environment, geography, etc.

The clinical manifestations of pancreatic tumors depend on the location of the cancer, the early or late course of the disease, the presence or absence of metastasis, and the involvement of adjacent organs. Its clinical characteristics are a short course of disease, rapid progression, and rapid deterioration. The most common symptoms are upper abdominal distension and pain. Although there is conscious pain, not all patients have tenderness. If there is tenderness, it is consistent with the location of conscious pain.

Pancreatic tumor is a highly malignant tumor with a very poor prognosis. The survival period of untreated pancreatic tumor patients is about 4 months, the survival period of patients undergoing bypass surgery is about 7 months, and patients can generally survive for 16 months after resection. Early diagnosis and early treatment are the key to improving the prognosis of pancreatic tumors. The use of adjuvant treatments such as radiotherapy and chemotherapy after surgery can improve the survival rate. For patients who receive surgical adjuvant chemotherapy and radiotherapy, the 2-year survival rate can reach 40%.

Expert tips: Pancreatic tumors are one of the most malignant tumors. The time from onset to death may be only a few months, so early treatment is very important. In addition to actively cooperating with treatment, pancreatic tumor patients should also pay more attention to rest, pay attention to diet conditioning, strive to improve the quality of life, and maximize life expectancy.